These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 16180015)
21. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [TBL] [Abstract][Full Text] [Related]
22. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
23. Parallel elevation of colonic 1,25-dihydroxyvitamin D3 levels and apoptosis in female mice on a calcium-deficient diet. Nittke T; Kallay E; Manhardt T; Cross HS Anticancer Res; 2009 Sep; 29(9):3727-32. PubMed ID: 19667171 [TBL] [Abstract][Full Text] [Related]
24. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat. Mandell E; Seedorf GJ; Ryan S; Gien J; Cramer SD; Abman SH Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L1018-26. PubMed ID: 26342089 [TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts. Gross C; Musiol IM; Eccleshall TR; Malloy PJ; Feldman D Biochem Biophys Res Commun; 1998 Jan; 242(3):467-73. PubMed ID: 9464239 [TBL] [Abstract][Full Text] [Related]
26. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Hedlund TE; Moffatt KA; Miller GJ Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485 [TBL] [Abstract][Full Text] [Related]
27. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193 [TBL] [Abstract][Full Text] [Related]
29. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602 [TBL] [Abstract][Full Text] [Related]
30. Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts. Avila E; Díaz L; Barrera D; Halhali A; Méndez I; González L; Zuegel U; Steinmeyer A; Larrea F J Steroid Biochem Mol Biol; 2007 Jan; 103(1):90-6. PubMed ID: 17079137 [TBL] [Abstract][Full Text] [Related]
31. Epigenetic regulation of the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) in colon cancer cells. Höbaus J; Fetahu ISh; Khorchide M; Manhardt T; Kallay E J Steroid Biochem Mol Biol; 2013 Jul; 136():296-9. PubMed ID: 22940288 [TBL] [Abstract][Full Text] [Related]
32. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase. Roy S; Martel J; Tenenhouse HS J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376 [TBL] [Abstract][Full Text] [Related]
33. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells. Peng X; Tiwari N; Roy S; Yuan L; Murillo G; Mehta RR; Benya RV; Mehta RG J Endocrinol; 2012 Feb; 212(2):207-15. PubMed ID: 22068926 [TBL] [Abstract][Full Text] [Related]
34. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Swami S; Krishnan AV; Peehl DM; Feldman D Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619 [TBL] [Abstract][Full Text] [Related]
35. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism. Tomon M; Tenenhouse HS; Jones G Endocrinology; 1990 Jun; 126(6):2868-75. PubMed ID: 2351099 [TBL] [Abstract][Full Text] [Related]
36. Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes. Morgan JW; Morgan DM; Lasky SR; Ford D; Kouttab N; Maizel AL J Immunol; 1996 Oct; 157(7):2900-8. PubMed ID: 8816395 [TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma. Ramnath N; Nadal E; Jeon CK; Sandoval J; Colacino J; Rozek LS; Christensen PJ; Esteller M; Beer DG; Kim SH J Thorac Oncol; 2014 Apr; 9(4):473-82. PubMed ID: 24736069 [TBL] [Abstract][Full Text] [Related]
39. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. Larriba MJ; Bonilla F; Muñoz A J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):106-9. PubMed ID: 20138990 [TBL] [Abstract][Full Text] [Related]